Event-related potential markers of brain changes in preclinical familial Alzheimer disease
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objectives: Event-related potentials (ERPs) can reflect differences in brain electrophysiology underlying cognitive functions in brain disorders such as dementia and mild cognitive impairment. To identify individuals at risk for Alzheimer disease (AD) we used high-density ERPs to examine brain physiology in young presymptomatic individuals (average age 34.2 years) who carry the E280A mutation in the presenilin-1 (PSEN1) gene and will go on to develop AD around the age of 45.
Methods: Twenty-one subjects from a Colombian population with familial AD participated: 10 presymptomatic subjects positive for the PSEN1 mutation (carriers) and 11 siblings without the mutation (controls). Subjects performed a visual recognition memory test while 128-channel ERPs were recorded.
Results: Despite identical behavioral performance, PSEN1 mutation carriers showed less positivity in frontal regions and more positivity in occipital regions, compared to controls. These differences were more pronounced during the 200–300 msec period. Discriminant analysis at this time interval showed promising sensitivity (72.7%) and specificity (81.8%) of the ERP measures to predict the presence of AD pathology.
Conclusions: Presymptomatic PSEN1 mutation carriers show changes in brain physiology that can be detected by high-density ERPs. The relative differences observed showing greater frontal positivity in controls and greater occipital positivity in carriers indicates that control subjects may use frontally mediated processes to distinguish between studied and unstudied visual items, whereas carriers appear to rely more upon perceptual details of the items to distinguish between them. These findings also demonstrate the potential usefulness of ERP brain correlates as preclinical markers of AD.
GLOSSARY
- AD=
- Alzheimer disease;
- aMCI=
- amnestic mild cognitive impairment;
- ANOVA=
- analysis of variance;
- CERAD=
- Consortium to Establish a Registry for Alzheimer's Disease;
- EOG=
- electro-oculography;
- ERP=
- event-related potential;
- FAD=
- familial AD;
- LAI=
- left anterior inferior;
- LPS=
- left posterior superior;
- ROI=
- region of interest
Footnotes
Study funding: Supported by the NIH/NIA (R01 AG025815, P30 AG13846 and K23 AG031925, COLCIENCIAS-Colombia [projects: 1115–343-19127; 1115–519-29028]) and the Boston University Department of Psychology. Dr. Budson's time was supported through the resources of VA Boston.
- Received December 13, 2010.
- Accepted April 19, 2011.
- Copyright © 2011 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Cortical event-related potentials in preclinical familial Alzheimer diseaseE. J. Golob, J. M. Ringman, R. Irimajiri et al.Neurology, November 16, 2009 -
Articles
MRS shows abnormalities before symptoms in familial Alzheimer diseaseA. K. Godbolt, A. D. Waldman, D. G. MacManus et al.Neurology, March 13, 2006 -
Article
Presymptomatic cortical thinning in familial Alzheimer diseaseA longitudinal MRI studyPhilip S.J. Weston, Jennifer M. Nicholas, Manja Lehmann et al.Neurology, October 12, 2016 -
Articles
Neuropsychological function in nondemented carriers of presenilin-1 mutationsJ. M. Ringman, C. Diaz-Olavarrieta, Y. Rodriguez et al.Neurology, August 22, 2005